Transform the Informed Consent process in clinical trials

Exom Group introduced Genius ENGAGE™ the first electronic Informed Consent (eIC) application combined with the cloud platform Genius eTMF™. When the site specific version of the ICF has been approved and filed into  Genius eTMF™,  than Genius Engage™ is triggered to provide Investigator and patient of the appropriate version of the ICF, for reading, understanding and signature.
Patients will benefit of better understanding of risks and benefits, improved learning through animation and visual imagery and more engagement into the study. Additionally,  investigators  will reduce complex & time-consuming explanations to patients and this will facilitate an higher enrollment and increased capability.

For more details please read PDF presentation of Genius ENGAGE™

Global Health & Pharma Excellence AwardsAward Winner 2022

Exom is proud to announce that Global Health & Pharma has awarded us the 2022 Global Excellence Award as "Most innovative Full-Service CRO - 2022" for our pioneering, cutting-edge use of technology in clinical trials to support study stakeholders.

Share This